Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer: Updates and beyond
Samar Al Bitar, Marwan El‐Sabban, Samer Doughan, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 9, pp. 1395-1426
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Clinical application of liquid biopsy in colorectal cancer: detection, prediction, and treatment monitoring
Xiang-Yuan Tao, Qianqian Li, Yong Zeng
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 10
MiR-3664-3p through suppressing ABCG2, CYP3A4, MCL1, and MLH1 increases the sensitivity of colorectal cancer cells to irinotecan.
Elham Farrokhnazar, Sahar Moghbelinejad, Reza Najafipour, et al.
Heliyon (2025), pp. e41933-e41933
Open Access | Times Cited: 1
Unmasking the Deceptive Nature of Cancer Stem Cells: The Role of CD133 in Revealing Their Secrets
Julia Pospieszna, Hanna Dams-Kozłowska, Wachirawit Udomsak, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10910-10910
Open Access | Times Cited: 14
Differential expression of angiogenesis-related genes ‘VEGF’ and ‘angiopoietin-1’ in metastatic and EMAST-positive colorectal cancer patients
Amir Torshizi Esfahani, Somayeh Mohammadpour, Pooya Jalali, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Ataxia telangiectasia and Rad3-related (ATR) inhibition by VE-822 potently reversed 5-flourouracil resistance in colorectal cancer cells through targeting DNA damage response
Ainaz Mihanfar, Faezeh Asghari, Maryam Majidinia
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 4
WEE1 Inhibition by AZD1775 Augments Colorectal Cancer Cells Susceptibility to VE-822-induced DNA Damage and Apoptosis
Ainaz Mihanfar, Faezeh Asghari, Maryam Majidinia
Drug Research (2025)
Closed Access
Five-gene expression signature associated with acquired FOLFIRI resistance and survival in metastatic colorectal cancer.
Elise Pretzsch, Christian Peschel, Matjaž Rokavec, et al.
Laboratory Investigation (2025), pp. 104107-104107
Open Access
Hsa-miR-526b-5p Regulates the Sensitivity of Colorectal Cancer to 5-Fluorouracil by Targeting TP53 in Organoid Models
Leaf Huang, Cun Liao, Zuming Xiong, et al.
Biochemical Genetics (2025)
Closed Access
Cinobufagin: Unveiling the hidden bufadienolide’s promise in combating alimentary canal cancer development and progression – a comprehensive review
Beatriz Leme Boaro, Enzo Pereira de Lima, Durvanei Augusto Maria, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Multi-omics analysis reveals Jianpi formula-derived bioactive peptide-YG-22 potentially inhibited colorectal cancer via regulating epigenetic reprogram and signal pathway regulation
Jun Wang, Li‐Juan Zhu, Yuanyuan Li, et al.
Frontiers in Genetics (2025) Vol. 16
Open Access
Tetramethylpyrazine induces reactive oxygen species-based mitochondria-mediated apoptosis in colon cancer cells
Yan-Xu Hou, Wei Ren, Qing-Qiang He, et al.
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 4
Closed Access
Recent developments on checkpoint inhibitors, CAR T cells, and beyond for T cell-based immunotherapeutic strategies against cancer
Shaukat Ali, Mahnoor Arshad, Muhammad Summer, et al.
Journal of Oncology Pharmacy Practice (2025)
Closed Access
Insights on the Role of Polyphenols in Combating Cancer Drug Resistance
Mohd Farhan
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1709-1709
Open Access | Times Cited: 12
Natural Products Treat Colorectal Cancer by Regulating miRNA
Shuoxi Guo, Meiqi Chen, Shuangyang Li, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1122-1122
Open Access | Times Cited: 12
Developing a Palladium(II) Agent to Overcome Multidrug Resistance and Metastasis of Liver Tumor by Targeted Multiacting on Tumor Cell, Inactivating Cancer-Associated Fibroblast and Activating Immune Response
Ming Jiang, Wenjuan Li, Jinzhe Liang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 18, pp. 16296-16310
Closed Access | Times Cited: 4
A perspective on emerging therapies in metastatic colorectal cancer: Focusing on molecular medicine and drug resistance
Anggraeni Endah Kusumaningrum, Sarce Makaba, Eyhab Ali, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 1
Closed Access | Times Cited: 3
Long Non-Coding RNAs in Drug Resistance of Gastric Cancer: Complex Mechanisms and Potential Clinical Applications
Xiangyu Meng, Xiao Bai, Ang-Ting Ke, et al.
Biomolecules (2024) Vol. 14, Iss. 6, pp. 608-608
Open Access | Times Cited: 3
A Review and Update on Therapy of Gastrointestinal Tract Tumors: From the Bench to Clinical Practice
María Jesús Fernández‐Aceñero, D. Hernandez, Cristina Díaz del Arco
Journal of Clinical and Translational Pathology (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 2
Aberrant FAM135B attenuates the efficacy of chemotherapy in colorectal cancer by modulating SRSF1-mediated alternative splicing
Wanmei Lin, Lijun Xu, Yaoying Li, et al.
Oncogene (2024) Vol. 43, Iss. 48, pp. 3532-3544
Closed Access | Times Cited: 2
Optimizing the first-line treatment for metastatic colorectal cancer
Sara Cherri, Ester Oneda, Laura Zanotti, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 6
Mitochondrial-Targeting Strategies with Homoharringtonine: A Novel Approach for Chemoresistant Rectal Cancer
Hu Chenghao, Xuefeng Liu, Pang Junli, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 743, pp. 151141-151141
Closed Access | Times Cited: 1
The bidirectional interplay between ncRNAs and methylation modifications in gastrointestinal tumors
Minyu Kong, Yu Xiao, Wenzhi Guo, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 15, pp. 4834-4848
Open Access | Times Cited: 4
Specific small interfering RNAs (siRNAs) for targeting the metastasis, immune responses, and drug resistance of colorectal cancer cells (CRC)
Harikumar Pallathadka, Chou‐Yi Hsu, Raed Obaid Saleh, et al.
International Immunopharmacology (2024) Vol. 140, pp. 112730-112730
Closed Access | Times Cited: 1
KLF7 enhances the invasion and migration of colorectal cancer cells via the miR-139-5p/TPD52 axis
Juan Zhang, Zhihan Li, Jiaxu Han, et al.
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
B7-H3 promotes the migration and invasion of colorectal cancer cells via regulating the actin cytoskeleton and RhoA/ROCK1/LIMK1 signaling pathway
Anjing Zhao, Xingchao Zhu, Hongya Wu, et al.
Tissue and Cell (2024) Vol. 90, pp. 102518-102518
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top